BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Hyundai Bioscience Launches Clinical Trials for Innovative Niclosamide-Based Cancer Drug

Clinical trials of Niclosamide-based oral metabolic anticancer drug to commence for patients with difficult-to-treat cancers such as triple-negative...

April 23, 2024 | News

Hyundai Bioscience to Conduct Global Clinical Trials for Groundbreaking Dengue Treatment

Hyundai Bioscience CEO Oh Sang-gi, announced its plan to launch global clinical trials for a revolutionary treatment targeting all four serotypes of ...

April 22, 2024 | News

CryptoLab and Macrogen Ink Deal to Integrate Advanced Encryption in Genomic Services

CryptoLab, a pioneer of fully homomorphic encryption (FHE) technology has announced the signing of a three-year supply contract with Macrogen, Korea'...

April 18, 2024 | News

New England Biolabs® Launches New Subsidiary in the Republic of Korea

The Republic of Korea is emerging as a global leader in the life science space, as a result of strong public sector support and private sector investments....

April 04, 2024 | News

Sebastian Arana Discusses Merck's Strategic Expansion in Asia-Pacific Through Innovative Bioprocessing Facility in Daejeon, South Korea

In an illuminating interview with BioPharma APAC, Sebastian Arana, Executive Vice President and Global Head of Process Solutions at Merck, shares insights ...

April 02, 2024 | Interview

Bridge Biotherapeutics Partners with Emory University to Advance Lung Cancer Treatment

Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announ...

April 01, 2024 | News

Bridge Biotherapeutics Partners with Emory University to Combat Lung Cancer Resistance

Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, ...

March 29, 2024 | News

Johnson & Johnson and Korean Health Ministry Launch Accelerator for Biotech & Medtech Startups

Johnson & Johnson Innovation – JLABS (JLABS) will activate its global network to enhance the competitiveness of Korean biotech and medtech startu...

March 29, 2024 | News

Bridge Biotherapeutics Partners with University of Colorado for Cancer Research

Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a...

March 27, 2024 | News

Lunit Reveals Positive Study Results for Head and Neck Cancer Immunotherapy

Lunit, a global leader in AI-driven cancer diagnostics and therapy solutions, is thrilled to share the publication of a groundbreaking study in the prestig...

March 27, 2024 | News

TiumBio Initiates Phase 1b Trial for New Hemophilia Treatment TU7710

TiumBio Co., Ltd., a trailblazer in the biopharmaceutical landscape, dedicated to crafting groundbreaking therapies for rare and untreatabl...

March 27, 2024 | News

DigmBio's Breakthrough Cancer Drug Clears Korean Regulatory Hurdle

BioDuro-Sundia's partner, DigmBio, a South Korean biotechnology company, announced its selective PARP1 inhibitor for the treatment of triple-negative breas...

March 26, 2024 | News

Oscotec Inc. Gains FDA Orphan Drug Designation for Promising ITP Treatment Cevidoplenib

Oscotec Inc. has secured orphan drug designation (ODD) from the U.S. Food and Drug Administration (FDA) for its SYK inhibitor, Cevidoplenib, to treat immun...

March 22, 2024 | News

SK bioscience Breaks Ground in Southeast Asia and Southern Hemisphere with 440,000 Dose Vaccine Export to Thailand

Company exported 440,000 doses to Thailand, marking its entry into the Southeast Asian market and the Southern Hemisphere market. Company has obtained m...

March 21, 2024 | News

Stay Connected